We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Global Urinalysis Market Driven by Growing Demand for Point-of-Care Diagnostic Testing

By LabMedica International staff writers
Posted on 01 Mar 2023
Print article
Image: The global urinalysis market is expected to reach USD 6.5 billion in 2030 (Photo courtesy of Pexels)
Image: The global urinalysis market is expected to reach USD 6.5 billion in 2030 (Photo courtesy of Pexels)

The global urinalysis market is projected to grow at a CAGR of 6.7% from USD 1.87 billion in 2021 to USD 2.87 billion by 2030, driven by the rising incidence of kidney and urinary tract disorders, growing demand for point-of-care diagnostic testing, increase in aging population and higher healthcare expenditure. In addition, the increasing prevalence of chronic diseases such as diabetes and hypertension, which are linked to kidney and urinary tract disorders, accompanied by technological advancements in urinalysis testing equipment, such as the development of automated urinalysis systems, is expected to fuel market growth.

These are the latest findings of Emergen Research (Vancover, BC, Canada), a market research and consulting company.

The increasing prevalence of kidney diseases and urinary tract infections, particularly among elderly individuals, is a key factor driving the urinalysis market growth. This has been accompanied by the rising occurrences of chronic conditions like diabetes and hypertension, leading to higher incidences of kidney and urinary tract conditions. Additionally, there is an increase in demand for point-of-care diagnostic tests, spurring the development of sophisticated urinalysis testing devices. These devices deliver accurate results quickly, making them a great option for use in ERs, outpatient clinics and other healthcare settings. Technology has also enabled the production of automated urinalysis systems which provide fast and precise results, making them perfect for high-throughput clinical laboratories.

Nevertheless, the market growth could be hindered by the high costs of automated urinalysis systems and other diagnostic testing devices. Additionally, a lack of skilled professionals to carry out diagnostic tests, especially in developing countries, could also impede market growth. Inaccurate results obtained from some urinalysis tests which can lead to misdiagnosis and inadequate treatment can also have a negative impact on market growth. Moreover, the absence of standardization in urinalysis testing processes could affect market growth, as different methods can result in different outcomes, making it difficult to compare results from different labs.

Currently, the urinalysis market is experiencing several trends and innovations including the emergence of advanced urinalysis testing devices and the growing use of point-of-care diagnostic tests. The use of AI and machine learning for urinalysis testing is also a trend that is likely to become more popular in the future. Furthermore, with the increasing demand for easy-to-use portable urinalysis test equipment, particularly in low-income settings, manufacturers are producing innovative devices that are cost-effective and require minimal training to operate.

Geographically, North America is expected to hold the largest revenue share in the global urinalysis market during the forecast period due to the rising prevalence of chronic renal disease, hypertension and diabetes, well-established sophisticated healthcare systems, and significant healthcare expenditure in the region. The European urinalysis market is expected to register a steady revenue growth over the forecast period owing to beneficial reimbursement policies and government guidelines and regulations, as well as developed healthcare infrastructure in the region. The Asia Pacific urinalysis market is expected to register a high revenue growth over the forecast period, thanks to the rapidly developing healthcare industry and increasing investments by key market players.

Related Links:
Emergen Research

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
POCT Fluorescent Immunoassay Analyzer
Gold Member
Automatic Nucleic Acid Extractor
GeneRotex 24

Print article


Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more


view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more


view channel
Image: The new AI tool can help beat brain tumors (Photo courtesy of Crystal Light/Shutterstock)

New AI Tool Classifies Brain Tumors More Quickly and Accurately

Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.